Kintara Therapeutics Inc. Gains 44.76%
Wed, May 29, 2024 at 07:25 PM
Kintara Therapeutics Inc. (KTRA:NASDAQ) soared at $0.27, representing a gain of 44.8%. On Wed, May 29, 2024, KTRA:NASDAQ hit a New 2-Week High of $0.27. The stock appeared on our News Catalysts scanner on Wed, May 15, 2024 at 04:39 AM in the 'EARNINGS' category. From Wed, May 15, 2024, the stock recorded 66.67% Up Days and 40.00% Green Days
About Kintara Therapeutics Inc. (KTRA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- Innovative Eyewear Inc. (LUCY:NASDAQ), 131.46%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 117.65%
- Brand Engagement Network Inc Com (BNAI:NASDAQ), 107.87%
- Onconetix Inc Com (ONCO:NASDAQ), 79.93%
- AST SpaceMobile Inc. (ASTS:NASDAQ), 69.23%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 44.76%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 28.21%
- Chewy, Inc. (CHWY:NYSE), 27.14%
- Nano Nuclear Energy Inc. (NNE:NASDAQ), 25.87%
- Ikena Oncology Inc. (IKNA:NASDAQ), 25.56%